[go: up one dir, main page]

PE20090358A1 - Composiciones agonistas de dopamina de liberacion controlada - Google Patents

Composiciones agonistas de dopamina de liberacion controlada

Info

Publication number
PE20090358A1
PE20090358A1 PE2008000930A PE2008000930A PE20090358A1 PE 20090358 A1 PE20090358 A1 PE 20090358A1 PE 2008000930 A PE2008000930 A PE 2008000930A PE 2008000930 A PE2008000930 A PE 2008000930A PE 20090358 A1 PE20090358 A1 PE 20090358A1
Authority
PE
Peru
Prior art keywords
controlled release
dopamine agonist
release
agonist compositions
release dopamine
Prior art date
Application number
PE2008000930A
Other languages
English (en)
Inventor
Jonathan David Bortz
Michael N Grimshaw
David Erokoboni
Original Assignee
Drugtech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Drugtech Corp filed Critical Drugtech Corp
Publication of PE20090358A1 publication Critical patent/PE20090358A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

REFERIDA A UNA FORMULACION FARMACEUTICA ORAL DE LIBERACION MULTIFASICA QUE COMPRENDE UN PRIMER Y SEGUNDO COMPONENTE QUE SON AGONISTAS DE DOPAMINA, DONDE EL PRIMER COMPONENTE PROPORCIONA UNA LIBERACION INMEDIATA Y EL SEGUNDO COMPONENTE PROPORCIONA UNA LIBERACION MODIFICADA DEL AGONISTA DE DOPAMINA, DONDE EL AGONISTA DE DOPAMINA ES (S)-2-AMINO-4,5,6,7-TETRAHIDRO-6-(PROPILAMINO)BENZOTIAZOL (PRAMIPEXOL). DICHA COMPOSICION ES UTIL EN EL TRATAMIENTO DE LA ENFERMEDAD DE PARKINSON, SINDROME DE PIERNAS INQUIETAS, TRANSTORNOS DEL SUENO, ENTRE OTROS
PE2008000930A 2007-06-04 2008-06-02 Composiciones agonistas de dopamina de liberacion controlada PE20090358A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93327107P 2007-06-04 2007-06-04

Publications (1)

Publication Number Publication Date
PE20090358A1 true PE20090358A1 (es) 2009-04-24

Family

ID=40088517

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008000930A PE20090358A1 (es) 2007-06-04 2008-06-02 Composiciones agonistas de dopamina de liberacion controlada

Country Status (5)

Country Link
US (1) US20080299189A1 (es)
AR (1) AR068792A1 (es)
CL (1) CL2008001622A1 (es)
PE (1) PE20090358A1 (es)
WO (1) WO2008150741A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120021057A1 (en) * 2009-04-09 2012-01-26 Purdue Pharma Once-daily oral ir/cr pramipexole formulation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7670612B2 (en) * 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
US20040166159A1 (en) * 2002-05-29 2004-08-26 Chien-Hsuan Han Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopa
US20050226926A1 (en) * 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
PA8578501A1 (es) * 2002-07-25 2005-02-04 Pharmacia Corp Forma de dosificacion una vez al dia de pramipexol
ES2337700T3 (es) * 2004-02-18 2010-04-28 Sepracor, Inc. Terapia combinada de agonista de dopamina con sedantes para mejorar la calidad del sueño.
US20060182805A1 (en) * 2005-02-15 2006-08-17 Jazz Pharmaceuticals Dosage form and method for sustained release of substituted pyrazine compound
US20070129329A1 (en) * 2005-12-02 2007-06-07 Alembic Limited Stabilized pharmaceutical composition of pramipexole and method of preparation thereof

Also Published As

Publication number Publication date
AR068792A1 (es) 2009-12-09
CL2008001622A1 (es) 2008-09-12
US20080299189A1 (en) 2008-12-04
WO2008150741A1 (en) 2008-12-11

Similar Documents

Publication Publication Date Title
PE20080056A1 (es) Derivados de cromencarboxamida como antagonistas del receptor s1p1
MX377802B (es) Metodos y composiciones para trastornos del sueño y otros trastornos.
CL2009000628A1 (es) Forma cristalina de 5-[3-(2,5-dicloro-4,6-dimetil-1-oxi-piridin-3-il)-[1,2,4]oxadiazol-5-il]-3-nitrobenceno-1,2-diol, composicion farmaceutica que la comprende, proceso para obtenerla y su uso para tratar trastornos del animo, enfermedad de parkinson y trastornos parkinsonianos, alteraciones gastrointestinales, entre otros.
BRPI0918309A8 (pt) Peça bocal para limpeza dos dentes
NZ612686A (en) Sublingual films
ECSP088239A (es) Composición de liberación de fármaco sostenida
CL2008002742A1 (es) Compuestos derivados de carboxialquilen-(bis-fenil-oxamida),agonistas del receptor gpr40; procedimiento de preparacion de las composiciones; composicion farmaceutica; y su uso en la prevencion o el tratamiento de hiperglicemia, diabetes, resistencia a la insulina, dislipidemia, esquizofrenia, enfermedad de alzheimer y demencia.
PE20081755A1 (es) Nuevas 2-aminooxazolinas como ligandos taar1
PE20110308A1 (es) 1,2,5-oxadiazoles como inhibidores de indolamina 2,3-dioxigenasa
BR112012006346A2 (pt) agonista de receptor de acetilcolina, composto, composição farmacêutica, combinação e uso de ativadores de receptor de acetilcolina nicotínico alfa 7
WO2005079851A3 (en) Dopamine-agonist combination therapy with sedatives for improving sleep quality
WO2008135527A3 (en) Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders
CO5190708A1 (es) Mezcla sinergica para el tratamiento del sindrome de piernas inquietas
MX2009002239A (es) Derivados de 5-(2-furil)-1,3-tiazol util como inhibidores de fosfatidilinositol 3-cinasa.
ECSP055569A (es) Forma de dosificación de pramipexol en una dosis única diaria
CL2008002808A1 (es) Compuestos derivados de benzoxazol, agonistas del receptor muscarinico m1; composicion farmaceutica que comprende a dichos compuestos; y uso para el tratamiento de esquizofrenia, alteraciones cognitivas o enfermedad de alzheimer.
EA200971107A1 (ru) Катехоламиновые производные, полезные для лечения болезни паркинсона
BRPI0908406B8 (pt) Derivados de quinoxalinona, processo para a preparação dos mesmos, seu uso e composição farmacêutica
IN2014DN09571A (es)
EP2328550A4 (en) MUCOADHERENT COMPOSITIONS AND THEIR USE
AR068845A1 (es) Composicion farmaceutica que contiene n-(3-metoxi-5-metilpirazin-2-il)-2-(4-((1,3,4-oxadiazol-2-il))fenil)piridin-3-sulfonamida util para el tratamiento del cancer
UA103779C2 (ru) Ветеринарная антипролактиновая композиция для жвачных
ES2452034T5 (es) Composición para el cuidado de prótesis dental
EA201390653A1 (ru) Aa антагонисты как усилители когнитивной и моторной функций
PE20091847A1 (es) Derivados de piridil-ptolinamida como antagonistas de receptores nk1

Legal Events

Date Code Title Description
FD Application declared void or lapsed